TASER® Electronic Control Device-Induced Rhabdomyolysis and Renal Failure: A Case Report
Published: October 1, 2015 | DOI: https://doi.org/10.7860/JCDR/2015/.6608
James Benjamin Gleason, Ibrahim Ahmad
1. Chief Fellow, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Florida, Weston, FL 33331, USA.
2. Clinical Assistant Professor, Department of Internal Medicine, Wright State University Boonshoft School of Medicine Kettering Medical Center, Kettering, OHIO, USA.
Correspondence
Dr. James Benjamin Gleason,
Chief Fellow, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Florida,
2950 Cleveland Clinic Boulevard, Weston, FL 33331, USA.
E-mail: gleasoj@ccf.org
Many law enforcement agencies around the United States are employing the use of TASER® electronic control devices (TASER® International Inc.) to subdue combative suspects. Since its inception the TASER® has had a temporal association with reports of rhabdomyolysis. Case reports have reported TASER® induced rhabdomyolysis as mild but serious cases have also been reported. Herein we present the case of a single patient who was admitted to our health network with severe rhabdomyolysis after receiving TASER® shocks and review the pertinent literature. No direct link has been established between clinically significant rhabdomyolysis and TASER® device application but this case serves as an example of a sparsely documented but serious complication that may occur in patients who are at risk for restraint by an electronic control device.
[
FULL TEXT ] | [ PDF]